Targeted potent antimicrobial and antitumor oxygen-heterocyclic-based pyran analogues: synthesis and computational studies.
Humans
Antineoplastic Agents
/ pharmacology
Pyrans
/ pharmacology
Microbial Sensitivity Tests
Cell Line, Tumor
Anti-Bacterial Agents
/ pharmacology
Molecular Docking Simulation
Heterocyclic Compounds
/ chemistry
Anti-Infective Agents
/ pharmacology
Structure-Activity Relationship
Escherichia coli
/ drug effects
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
29 04 2024
29 04 2024
Historique:
received:
01
01
2024
accepted:
08
04
2024
medline:
30
4
2024
pubmed:
30
4
2024
entrez:
29
4
2024
Statut:
epublish
Résumé
The process of creating a series of 3-amino-1-aryl-8-methoxy-1H-benzo[f]chromene-2-carbonitriles (4a-q) involved reacting 6-methoxynaphthalen-2-ol (1), the appropriate aromatic aldehydes (2a-q), and malononitrile (3) in an absolute ethanol/piperidine solution under Ultrasonic irradiation. However, the attempt to create 3-amino-1-aryl-1H-benzo[f]chromene-2,8-dicarbonitrile (6a, d, e) was unsuccessful when 6-cyanonaphthalen-2-ol (5) was stirred at room temperature, reflux, Microwave irradiation, or Ultrasonic irradiation. In addition, the target molecules were screened against Staphylococcus aureus (MRSA), Staphylococcus aureus, Bacillus subtilis, Bacillus cereus, Escherichia coli and Klebsiella pneumonia, as well as a panel of three human cancer cells lines such as MCF-7, HCT-116, HepG-2 and two normal cell lines HFL-1 and WI-38. The obtained results confirmed that the pyran derivatives (4 m, i, k) which have a double chlorine at 3,4/2,3/2,5-positions, a single halogen atom 3-Cl/4-Br (4c, e) and a double bromine at 3,5-positions with a single methoxy group at 2-position (4n), of phenyl ring, and, to a lesser extent, other pyran derivatives with monoihalogenated (4a, b, d, f), dihalogenated (4 g, h, j, l) or trisubstituent phenyl ring (4o, p, q). Furthermore, compounds 4b-e, g, i, j, m, and n showed negligible activity against the two normal cell lines, HFL-1 and WI-38. Moreover, compound 4 g exhibited the strongest antimicrobial activity among the other pyran derivatives (4a-f, g-q) when compared to Ciprofloxacin. The MIC was assessed and screened for compound 4 g, revealing bactericidal effects. Lastly, SAR and molecular docking were studied.
Identifiants
pubmed: 38684707
doi: 10.1038/s41598-024-59193-2
pii: 10.1038/s41598-024-59193-2
doi:
Substances chimiques
Antineoplastic Agents
0
Pyrans
0
Anti-Bacterial Agents
0
Heterocyclic Compounds
0
Anti-Infective Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
9862Informations de copyright
© 2024. The Author(s).
Références
EXCLI J. 2017 Jun 19;16:868-902
pubmed: 28828001
Beilstein J Org Chem. 2011;7:1688-96
pubmed: 22238548
Bioorg Chem. 2019 Dec;93:103289
pubmed: 31586716
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Biomol Struct Dyn. 2023;41(21):12411-12425
pubmed: 36661285
Bioorg Chem. 2019 Mar;84:202-210
pubmed: 30502632
Clin Microbiol Infect. 2000 Sep;6(9):509-15
pubmed: 11168187
J Med Chem. 2007 Aug 23;50(17):4250-4
pubmed: 17655212
Bioorg Chem. 2020 Jan;95:103549
pubmed: 31887476
Bioorg Chem. 2020 May;98:103725
pubmed: 32199303
Bioorg Chem. 2019 Dec;93:103329
pubmed: 31590040
Eur J Med Chem. 2019 Feb 1;163:160-168
pubmed: 30503940
Acta Crystallogr D Biol Crystallogr. 2009 Aug;65(Pt 8):751-7
pubmed: 19622858
Biochem J. 2012 Dec 15;448(3):417-23
pubmed: 23101586
Front Chem. 2021 Nov 22;9:759148
pubmed: 34881224
Daru. 2012 Dec 26;20(1):100
pubmed: 23351304
Naunyn Schmiedebergs Arch Pharmacol. 2014 Dec;387(12):1199-208
pubmed: 25261336
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2155814
pubmed: 36662632
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1074-1088
pubmed: 29923425
Bioorg Chem. 2020 Aug;101:103992
pubmed: 32554279
Anticancer Agents Med Chem. 2017;17(3):464-470
pubmed: 27357544
Bioorg Chem. 2020 Dec;105:104387
pubmed: 33130344
Molecules. 2019 Mar 18;24(6):
pubmed: 30889862
Int J Mol Sci. 2022 Dec 20;24(1):
pubmed: 36613493
Acta Crystallogr Sect E Struct Rep Online. 2013 Mar 02;69(Pt 4):o476-7
pubmed: 23634033
Bioorg Chem. 2019 Nov;92:103262
pubmed: 31518757
Future Med Chem. 2013 Sep;5(14):1647-60
pubmed: 24047270
Eur J Med Chem. 2021 Mar 5;213:113049
pubmed: 33279291
Bioorg Chem. 2021 Nov;116:105402
pubmed: 34670333
J Antimicrob Chemother. 2006 Dec;58(6):1107-17
pubmed: 17040922
Z Naturforsch C J Biosci. 2017 May 1;72(5-6):161-171
pubmed: 27831925
Eur J Med Chem. 2018 Sep 5;157:380-396
pubmed: 30099258
Molecules. 2016 Nov 01;21(11):
pubmed: 27809292